AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net selling: insiders sold $2.7M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$2.7M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 6 added, 5 cutMore adding
Key stats
Fundamentals Sep 30- Open
- $199.90
- 52-wk high
- $218.60
- High
- $201.27
- 52-wk low
- $160.31
- Low
- $196.48
- Prev close
- $200.58
- Mkt cap
- $79.00B
- P/E
- 39.5x
- Volume
- 2.00M
- Fwd P/E
- 36.2x
- Beta
- 0.91
- Div yield
- 0.93%
- P/S
- 6.8x
- P/B
- 15.4x
- Profit margin
- +17.8%
- Op margin
- +24.1%
- ROE
- +41.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CTAS filings
Are insiders buying or selling Cintas Corporation (CTAS) stock?
Net selling: insiders sold $2.7M and bought $0 of CTAS stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. The largest was Barstad, Melanie W. (Director), who sold $1.9M. The latest filing was on Jul 23, 2026.
Which members of Congress have traded CTAS recently?
None. No member of Congress disclosed a CTAS trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this CTAS smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- MI
Millennium
$97.7M
added
Sells/Trims (2)
- QR
Qube Research
$142.4M
trimmed
- CI
Citadel
$139.4M
trimmed
What insiders are doing
How top traders are positioned
No tracked top-trader positions in CTAS right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 3.0% above what analysts expected.
Earnings per share
$1.35 expected
Revenue
$2.98B expected
GAAP EPS was $1.36 and adjusted EPS was $1.39. The analyst basis could not be confirmed, so no beat or miss is shown.
What the street expects next
Estimates as of Sep 29, 2026
EPS expected
$1.34 to $1.39
Revenue expected
12 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Aug 2025 | Nov 2025 | Feb 2026 | May 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.72B | $2.80B | $2.84B | $2.91B |
| Cost of what it sold | $1.35B | $1.39B | $1.39B | $1.42B |
| Gross profit | $1.37B | $1.41B | $1.45B | $1.48B |
| What it spent | ||||
| Sales and admin | $748.7M | $756.8M | $788.6M | $792.1M |
| Other operating costs | — | — | — | $15.1M |
| Total operating expenses | $748.7M | $756.8M | $788.6M | $807.3M |
| What was left | ||||
| Operating profit | $617.9M | $655.7M | $659.9M | $673.0M |
| Interest on debt | $24.2M | $28.1M | $28.2M | $25.8M |
| Profit before tax | $595.9M | $628.5M | $632.5M | $648.4M |
| Tax | $104.8M | $133.2M | $130.0M | $137.4M |
| Net profit | $491.1M | $495.3M | $502.5M | $511.0M |
| EBITDA | $746.0M | $783.2M | $789.4M | $673.0M |
Technicals
Price structure
This stock's price action is mixed.
Trend
Mixed
40 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace